Patent Application
Utility
App. No. 18/299,664
· Confirmation No. 8419
ANTI-INFECTIVE METHODS, COMPOSITIONS, AND DEVICES
Applicant:
Bausch Health Ireland Limited
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-07-02 | ABN |
Abandonment | 2 | View | |
| 2024-12-27 | CTMS |
Miscellaneous Action with shortened statutory period (SSP) | 4 | View | |
| 2024-10-31 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | — | View | |
| 2024-10-31 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2024-10-31 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-10-31 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2024-10-31 | CLM |
Claims | 3 | View | |
| 2024-10-31 | REM |
Applicant Arguments/Remarks Made in an Amendment | 3 | View | |
| 2024-10-31 | XT/ |
Extension of Time | 2 | View | |
| 2024-10-31 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2024-05-01 | CTNF |
Non-Final Rejection | 12 | View | |
| 2024-05-01 | 892 |
List of references cited by examiner | 1 | View | |
| 2024-05-01 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2024-05-01 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2024-05-01 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2024-05-01 | SRNT |
Examiner's search strategy and results | 15 | View | |
| 2024-05-01 | 1449 |
List of References cited by applicant and considered by examiner | 3 | View | |
| 2024-05-01 | SRNT |
Examiner's search strategy and results | 10 | View | |
| 2024-05-01 | 1449 |
List of References cited by applicant and considered by examiner | 12 | View | |
| 2024-05-01 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2024-01-17 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-01-17 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2024-01-08 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-01-08 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2023-09-22 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2023-08-17 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2023-08-17 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2023-08-14 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2023-08-14 | PA.. |
Power of Attorney | 2 | View | |
| 2023-07-18 | TRAN.LET |
Transmittal Letter | — | View | |
| 2023-07-18 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2023-07-18 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 3 | View | |
| 2023-07-18 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 12 | View | |
| 2023-06-12 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2023-06-12 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2023-06-07 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 1 | View | |
| 2023-06-07 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 1 | View | |
| 2023-06-07 | A.PE |
Preliminary Amendment | 1 | View | |
| 2023-06-07 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2023-06-07 | DRW |
Drawings-only black and white line drawings | 2 | View | |
| 2023-06-07 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2023-04-28 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2023-04-28 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2023-04-28 | NT.CR.APP.PA |
Notice to File Corrected Application Papers | 2 | View | |
| 2023-04-12 | SPEC |
Specification | — | View | |
| 2023-04-12 | PA.. |
Power of Attorney | 2 | View | |
| 2023-04-12 | SPEC |
Specification | 57 | View | |
| 2023-04-12 | CLM |
Claims | 2 | View | |
| 2023-04-12 | ABST |
Abstract | 1 | View | |
| 2023-04-12 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2023-04-12 | OATH |
Oath or Declaration filed | 2 | View | |
| 2023-04-12 | ADS |
Application Data Sheet | 9 | View | |
| 2023-04-12 | DRW.NONBW |
Drawings-other than black and white line drawings | 6 | View | |
| 2023-04-12 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2023-04-12 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View | |
| 2023-04-12 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View |
Inventors
Radhakrishnan PILLAI
Santa Rosa, CA
Gordon DOW
Greenbrae, CA
Attorneys & Agents of Record
Classification
USPC
514/326
A61K31/454
Y10T83/0443
A61P17/00
A61P31/10
A61K9/0014
A61K47/06
A61K47/10
A61K47/12
A61K47/14
A61K47/18
A61K47/24
Prosecution
- Examiner
- ANDERSON, JAMES D
- Art Unit
- 1629
- Customer No.
- 193452
- Docket No.
- 134003-5012-US05
- Confirmation No.
- 8419
Publication
- Pub. No.
- US20230293508A1
- Pub. Date
- 2023-09-21
Parent
is a Continuation of
→
App. 17/062,973
· US 11,654,139
Filed 2020-10-05
· Patented Case
Parent
is a Continuation of
→
App. 16/353,849
· US 10,828,293
Filed 2019-03-14
· Patented Case
Parent
is a Continuation of
→
App. 14/552,307
· US 10,245,257
Filed 2014-11-24
· Patented Case
Parent
Claims priority from a provisional application
→
App. 61/907,401
Filed 2013-11-22
· Provisional Application Expired
U.S. PATENT SECURITY AGREEMENT
Recorded 2025-11-25
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2023-08-25
SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2023-08-25
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2023-08-25
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2023-04-12
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2023-04-12
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 18/299,664
- Filed
- 2023-04-12
- Pub. No.
- US20230293508A1
- Examiner
- ANDERSON, JAMES D
- Art Unit
- 1629
External Links